Case Type: Mergers & Acquisitions

Greenlane Holdings, Inc. (GNLN) relating to its proposed merger with KushCo Holdings, Inc. Under the terms of the agreement, KushCo shareholders will receive 0.2546 shares of Greenlane per share they own.

Research Alliance Corp. I (RACA) relating to its proposed merger with POINT Biopharma, Inc. Under the terms of the agreement, RACA will acquire POINT through a reverse merger, with POINT emerging as a publicly traded company.

Alpha Healthcare Acquisition Corp. (AHAC) relating to its proposed merger with Humacyte, Inc. Under the terms of the agreement, AHAC will acquire Humacyte through a reverse merger, with Humacyte emerging as a publicly traded company.

Chardan Healthcare Acquisition 2 Corp. (CHAQ) relating to its proposed merger Renovacor, Inc. Under the terms of the agreement, CHAQ will acquire Renovacor through a reverse merger, with Renovacor emerging as a publicly traded company.

Alberton Acquisition Corp. (ALAC) relating to its proposed merger with SolarMax Technology, Inc.

Support.com, Inc. (SPRT) relating to its proposed merger with Greenidge Generation Holdings. Under the terms of the agreement, SPRT shareholders will own only 8% of the combined company.

Kansas City Southern (KSU) relating to its proposed acquisition by Canadian Pacific Railway. Under the terms of the agreement, KSU shareholders will receive $90.00 in cash and 0.489 shares of Canadian Pacific per share they own.

Intec Pharma Ltd. (NTEC) relating to its proposed merger with Decoy Biosystems. Under the terms of the agreement, NTEC shareholders will own 25% of the combined company.

SYNNEX Corp. (SNX) relating to its proposed merger with Tech Data, a subsidiary of Apollo Global Management, Inc. Under the terms of the agreement, SNX will own approximately 55% of the newly combined company.

Jaws Spitfire Acquisition Corp. (SPFR) relating to its proposed merger with VELO3D. Under the terms of the agreement, SPFR shareholders will own only 16.5% of the combined company.